Phreesia Inc (PHR)
22.61
-0.02
(-0.09%)
USD |
NYSE |
May 28, 16:00
22.60
0.00 (0.00%)
Pre-Market: 20:00
Phreesia Cash from Financing (Quarterly): -4.61M for Jan. 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | -4.61M |
October 31, 2023 | -2.284M |
July 31, 2023 | -3.043M |
April 30, 2023 | -7.178M |
January 31, 2023 | -10.41M |
October 31, 2022 | -3.664M |
July 31, 2022 | -2.766M |
April 30, 2022 | -3.965M |
January 31, 2022 | -7.934M |
October 31, 2021 | -0.425M |
July 31, 2021 | -0.943M |
April 30, 2021 | 244.27M |
Date | Value |
---|---|
January 31, 2021 | -25.43M |
October 31, 2020 | 174.29M |
July 31, 2020 | 0.689M |
April 30, 2020 | 1.111M |
January 31, 2020 | 0.817M |
October 31, 2019 | -2.107M |
July 31, 2019 | 96.49M |
April 30, 2019 | 5.062M |
January 31, 2019 | 6.614M |
October 31, 2018 | -0.2623M |
July 31, 2018 | -1.466M |
April 30, 2018 | -0.6923M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-25.43M
Minimum
Jan 2021
244.27M
Maximum
Apr 2021
23.31M
Average
-2.284M
Median
Oct 2023
Cash from Financing (Quarterly) Benchmarks
American Shared Hospital Services | 2.282M |
Novo Integrated Sciences Inc | 0.0032M |
Astrana Health Inc | 106.35M |
Cryo-Cell International Inc | 0.539M |
P3 Health Partners Inc | 11.40M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -3.078M |
Cash from Investing (Quarterly) | -8.158M |
Free Cash Flow | -57.48M |
Free Cash Flow Per Share (Quarterly) | -0.196 |
Free Cash Flow to Equity (Quarterly) | -14.09M |
Free Cash Flow to Firm (Quarterly) | -10.94M |
Free Cash Flow Yield | -4.66% |